get a key
steadybase-$ company PLRZ
account_id none on file
legal_name Polyrizon Ltd.
ticker PLRZ
cik 1893645
domain polyrizon-biotech.com
linkedin_company_url none on file
entry_point_account_id none on file
exchange Nasdaq
calls 0 filings 5 executives 0 family 0
why_nownone on file
callsnone on file
filings
International expansion of our business exposes us to business, regulatory, political, operational, financial and economic risks associated with doing business outside of the United States or Israel.

filing / Mar 25, 2026 / receipt

healthcare industry and elsewhere has been cost containment, including price controls, restrictions on coverage and reimbursement and requirements for substitution of less expensive products and procedures.

filing / Mar 25, 2026 / receipt

implementation of any future governmental cost containment or other health reform initiative may result in additional downward pressure

filing / Mar 25, 2026 / receipt

of these factors could significantly harm our future international expansion and operations and, consequently, our results of operations.

filing / Mar 25, 2026 / receipt

consider that our current office space is sufficient to meet our anticipated needs for the foreseeable future and is suitable for the

filing / Mar 25, 2026 / receipt

executivesnone on file
familynone on file
upcomingnone on file
changesnone on file
mcp_package_hint
steadybase-$